Ignite Creation Date:
2025-12-25 @ 2:02 AM
Ignite Modification Date:
2026-02-24 @ 6:24 AM
Study NCT ID:
NCT01405560
Status:
COMPLETED
Last Update Posted:
2018-10-18
First Post:
2011-07-28
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Are Non-responders to Previous Treatment (MK-7009-045)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-09-02
Start Date Type:
ACTUAL
Primary Completion Date:
2013-03-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-03-29
Completion Date Type:
ACTUAL
First Submit Date:
2011-07-28
First Submit QC Date:
None
Study First Post Date:
2011-07-29
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2014-10-06
Results First Submit QC Date:
None
Results First Post Date:
2014-10-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-09-21
Last Update Post Date:
2018-10-18
Last Update Post Date Type:
ACTUAL